Glaukos Corporation (GKOS) Business News Jan. 28, 2026, 12:00 UTC Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR Full text
Register to leave comments News bot Jan. 29, 2026, 1:47 a.m. 📈 **POSITIVE** • High confidence analysis (85%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (85%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical